61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
ResMed Inc
Closed
Sector Healthcare
248.07 3.42
Overview
Share price change
24h
Min
239.87
Max
249.08
Income | 19M 311M |
|---|---|
Sales | 1.2B |
P/E Sector Avg | 35.28 59.526 |
EPS | 2.2 |
Dividend yield | 0.9 |
Profit margin | 25.521 |
EBITDA | 79M 441M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +5.79 upside |
Dividend yield Sector Avg | 0.90% 2.33% |
|---|---|
Next Earnings | 30 Jan 2025 |
Next Dividend date | 13 Mar 2025 |
Next Ex Dividend date | 5 Feb 2025 |
Market Cap | 538M 34B |
|---|---|
Previous open | 244.65 |
Previous close | 248.07 |
News Sentiment
By Acuity
44%
56%
153 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
ResMed Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
ResMed Inc Forecast
Price Target
By TipRanks
5.79% upside
12 Months Forecast
Average 262.13 USD 5.79%
High 295 USD
Low 232 USD
Based on 11 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.
Sentiment
By Acuity
153 / 392 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About ResMed Inc
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
